We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cutting-Edge Medical Device Purifies and Concentrates Urine for Rapid Cancer Diagnosis

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: The device has the potential for improving the early detection of various diseases (Photo courtesy of Bangor University)
Image: The device has the potential for improving the early detection of various diseases (Photo courtesy of Bangor University)

A groundbreaking medical device designed to purify and concentrate urine has the potential to revolutionize research and diagnosis of various health issues, including cancer.

Developed by Bee Robotics (based in Wales, UK) in collaboration with Bangor University (Gwynedd, UK), this prototype effectively processes urine to generate concentrated samples suitable for biological analysis. By collaborating with Bangor University, Bee Robotics was able to analyze and evaluate the automated procedure, resulting in more reliable test outcomes through the concentration and purification of urine samples. The automation aspect of this technology distinguishes it from traditional sample analysis methods, enabling faster processing times.

Complete automation minimizes the need for human involvement, marking a significant advancement in the diagnosis and research of various medical conditions. Although the research is still in its early phases, the scientific principles underlying the process have been a key focus for the team. Researchers intend to continue refining the methodology and advancing the prototype, which allows for sample concentration while minimizing inhibitors to improve the sensitivity of diagnostic tests.

Related Links:
Bangor University
Bee Robotics

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Aspergillus Test
REALQUALITY Aspergillus
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.